Results 181 to 190 of about 24,701 (248)

Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial. [PDF]

Reprod Health
Guo H, Du T, Gao H, Xi Q, Wu L, Lyu Q, Zhu Q.   +6 more
europepmc   +1 more source

Serum concentrations of medroxyprogesterone acetate were undetectable on OPU+5 days and had no effect on the serum progesterone level in patients undergoing the progestin-primed ovarian stimulation protocol. [PDF]

Front Endocrinol (Lausanne)
Chen X, Yan X, Xu H, Hu Y, Jiang S, Wang X, Peng H, Feng B, Zhang C, Diao H, Zhang Y.   +10 more
europepmc   +1 more source

Optimizing maternal and neonatal outcomes with postpartum contraception: impact on breastfeeding and birth spacing [PDF]

, 2017

core   +1 more source

Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications. [PDF]

Contraception
Dutton C, Mody SK, Nippita S, Dodge LE, Pang T, Pennell PB, Davis A.   +6 more
europepmc   +1 more source

Depot Medroxyprogesterone Acetate or Oral Contraception in Postpartum Adolescents

, 1998
C O'dell
openalex   +1 more source

Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate

, 2012
Shunjun Zhao, Genxia Li, Li Yang, Lei Li, Hongyu Li   +4 more
openalex   +2 more sources

Mammary carcinoma in a male cat following long-term medroxyprogesterone acetate treatment: case report and review of the literature. [PDF]

Vet Res Commun
Pîrvu AM, Cappelleri A, Sala L, Banco B, Giudice C, Stefanello D, Militaru M, Grieco V.   +7 more
europepmc   +1 more source

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

, 2014
Kathy D. Miller, Sandra K. Althouse, Lisle M. Nabell, Hope S. Rugo, Lisa A. Carey, Gretchen Kimmick, David Jones, Maria J. Merino, Patricia S. Steeg   +8 more
openalex   +2 more sources

Depot medroxyprogesterone acetate and breast cancer: a systematic review. [PDF]

Arch Gynecol Obstet
Zürcher A, Knabben L, von Gernler M, Stute P.   +3 more
europepmc   +1 more source

Injection Depot Medroxyprogesterone Acetate as an Early Postpartum Contraceptive Measure: Evaluation of Its Acceptability, Efficacy, and Impact on Lactation. [PDF]

Cureus
Srivastava Garg S, Bhateja B, Grover S, Tapasvi I.   +3 more
europepmc   +1 more source